BACKGROUND & AIMS: Signal transducer and activator of transcription 3 (STAT3), a key mediator of anti-inflammatory cytokine signaling, is essential for heme oxygenase-1 (HO-1)-induced cytoprotection. The phosphoinositide 3-kinase (PI3K)/phosphatase and tensin homolog delete on chromosome 10 (PTEN) pathways regulate diverse innate immune responses. This study was designed to investigate the role of STAT3 in the regulation of PI3K/PTEN cascade after HO-1 induction in a mouse model of innate immune-dominated liver ischemia/reperfusion injury (IRI). METHODS: Partial warm ischemia was produced in the left and middle hepatic lobes of C57BL/6 mice for 90 min, followed by 6h of reperfusion. RESULTS: Mice subjected to Ad-HO-1 transfer were resistant to liver IRI, and this cytoprotective effect correlated with increased intrahepatic PI3K/Akt and diminished PTEN expression. In contrast, mice undergoing adjunctive Ad-HO-1 treatment and STAT3 knockdown (siRNA) remained susceptible to IR-mediated local inflammatory response and hepatocellular damage. Consistent with decreased cell apoptosis and inhibited TLR4 expression after PI3K/Akt activation, treatment with specific PI3k inhibitor increased local inflammation and recreated liver IRI despite Ad-HO-1 gene transfer. Parallel in vitro studies with bone marrow derived-macrophages have confirmed that HO-1-STAT3 axis-induced PI3K/Akt negatively regulated PTEN expression in TLR4-dependent fashion. CONCLUSIONS: These findings underscore the role of HO-1 induced STAT3 in modulating PI3K/PTEN in liver IRI cascade. Activating PI3K/Akt provides negative feedback mechanism for TLR4-driven inflammation. Identifying molecular pathways of STAT3 modulation in the innate immune system provides the rationale for novel therapeutic approaches for the management of liver inflammation and IRI in transplant patients.
BACKGROUND & AIMS:Signal transducer and activator of transcription 3 (STAT3), a key mediator of anti-inflammatory cytokine signaling, is essential for heme oxygenase-1 (HO-1)-induced cytoprotection. The phosphoinositide 3-kinase (PI3K)/phosphatase and tensin homolog delete on chromosome 10 (PTEN) pathways regulate diverse innate immune responses. This study was designed to investigate the role of STAT3 in the regulation of PI3K/PTEN cascade after HO-1 induction in a mouse model of innate immune-dominated liver ischemia/reperfusion injury (IRI). METHODS: Partial warm ischemia was produced in the left and middle hepatic lobes of C57BL/6 mice for 90 min, followed by 6h of reperfusion. RESULTS:Mice subjected to Ad-HO-1 transfer were resistant to liver IRI, and this cytoprotective effect correlated with increased intrahepatic PI3K/Akt and diminished PTEN expression. In contrast, mice undergoing adjunctive Ad-HO-1 treatment and STAT3 knockdown (siRNA) remained susceptible to IR-mediated local inflammatory response and hepatocellular damage. Consistent with decreased cell apoptosis and inhibited TLR4 expression after PI3K/Akt activation, treatment with specific PI3k inhibitor increased local inflammation and recreated liver IRI despite Ad-HO-1 gene transfer. Parallel in vitro studies with bone marrow derived-macrophages have confirmed that HO-1-STAT3 axis-induced PI3K/Akt negatively regulated PTEN expression in TLR4-dependent fashion. CONCLUSIONS: These findings underscore the role of HO-1 induced STAT3 in modulating PI3K/PTEN in liver IRI cascade. Activating PI3K/Akt provides negative feedback mechanism for TLR4-driven inflammation. Identifying molecular pathways of STAT3 modulation in the innate immune system provides the rationale for novel therapeutic approaches for the management of liver inflammation and IRI in transplant patients.
Authors: L Arbibe; J P Mira; N Teusch; L Kline; M Guha; N Mackman; P J Godowski; R J Ulevitch; U G Knaus Journal: Nat Immunol Date: 2000-12 Impact factor: 25.606
Authors: F Amersi; R Buelow; H Kato; B Ke; A J Coito; X D Shen; D Zhao; J Zaky; J Melinek; C R Lassman; J K Kolls; J Alam; T Ritter; H D Volk; D G Farmer; R M Ghobrial; R W Busuttil; J W Kupiec-Weglinski Journal: J Clin Invest Date: 1999-12 Impact factor: 14.808
Authors: Bibo Ke; Xiu-Da Shen; Feng Gao; Haofeng Ji; Bo Qiao; Yuan Zhai; Douglas G Farmer; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Mol Ther Date: 2009-12-22 Impact factor: 11.454
Authors: Xiu-Da Shen; Bibo Ke; Yuan Zhai; Farin Amersi; Feng Gao; Dean M Anselmo; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Transplantation Date: 2002-08-15 Impact factor: 4.939
Authors: H Kato; F Amersi; R Buelow; J Melinek; A J Coito; B Ke; R W Busuttil; J W Kupiec-Weglinski Journal: Am J Transplant Date: 2001-07 Impact factor: 8.086
Authors: Murugabaskar Balan; Eduardo Mier y Teran; Ana Maria Waaga-Gasser; Martin Gasser; Toni K Choueiri; Gordon Freeman; Soumitro Pal Journal: J Biol Chem Date: 2015-02-02 Impact factor: 5.157
Authors: Qiang Zhu; Changyong Li; Kunpeng Wang; Shi Yue; Longfeng Jiang; Michael Ke; Ronald W Busuttil; Jerzy W Kupiec-Weglinski; Feng Zhang; Ling Lu; Bibo Ke Journal: Liver Transpl Date: 2017-06 Impact factor: 5.799
Authors: Kojiro Nakamura; Shoichi Kageyama; Bibo Ke; Takehiro Fujii; Rebecca A Sosa; Elaine F Reed; Nakul Datta; Ali Zarrinpar; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Liver Transpl Date: 2017-10 Impact factor: 5.799
Authors: Shoichi Kageyama; Hirofumi Hirao; Kojiro Nakamura; Bibo Ke; Min Zhang; Takahiro Ito; Antony Aziz; Damla Oncel; Fady M Kaldas; Ronald W Busuttil; Rebecca A Sosa; Elaine F Reed; Jesus A Araujo; Jerzy W Kupiec-Weglinski Journal: Am J Transplant Date: 2018-08-24 Impact factor: 8.086
Authors: Md Jamal Uddin; Yeonsoo Joe; Min Zheng; Perry J Blackshear; Stefan W Ryter; Jeong Woo Park; Hun Taeg Chung Journal: Free Radic Biol Med Date: 2013-10-02 Impact factor: 7.376